500830 (500830) Fair Value & Analysis
IN · Market cap ₹466B
Fair value as of: Jul 4, 2026
From 23 valuation models · updated 6 days ago
Share price +1.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹1,768 – ₹2,411 · fair‑value band ₹850.35 – ₹1,395 · the ₹2,044 price screens above the ₹1,129 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
500830 (500830) currently trades at ₹2,044, while our model-based Fair Value estimate is ₹1,129 — implying the stock looks roughly 44.8% overvalued today. We read business quality at 72/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
The stock trades on a trailing P/E of 45.0. Fundamentals as of Jul 4, 2026
Our scenario range runs from ₹850.35 (bear case) to ₹1,395 (bull case); at ₹2,044, the current price sits above that range. The share trades about 17% below its 52-week high and 16% above its 52-week low.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
500830 reported revenue of ₹59.8B in FY2025 versus ₹51.0B in FY2021, a compound +4.1%/yr. Reported net income was ₹13.3B in FY2025, compounding +5.3%/yr from FY2021.
Is 500830 fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is 500830 (500830) undervalued?
What is the fair value of 500830?
What is the quality score of 500830?
What is the net profit margin of 500830?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
The 25 strongest value stocks, free every month
Enter your email to get the free monthly Top-25 report of the most undervalued quality stocks from 35,000+ analysed. Unsubscribe anytime.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.